ENBIO Co., Ltd. (KOSDAQ:352940)
South Korea
· Delayed Price · Currency is KRW 2,450.00
-10.00 (-0.41%)
At close: Apr 21, 2025, 3:30 PM KST
ENBIO Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 35,654 | 34,024 | 34,240 | 33,466 | 34,563 | Upgrade
|
| Other Revenue | -0 | -0 | - | - | - | Upgrade
|
| Revenue | 35,654 | 34,024 | 34,240 | 33,466 | 34,563 | Upgrade
|
| Revenue Growth (YoY) | 4.79% | -0.63% | 2.31% | -3.17% | 2.45% | Upgrade
|
| Cost of Revenue | 24,081 | 26,970 | 27,898 | 22,713 | 20,231 | Upgrade
|
| Gross Profit | 11,573 | 7,055 | 6,342 | 10,753 | 14,332 | Upgrade
|
| Selling, General & Admin | 8,864 | 9,052 | 8,859 | 7,562 | 6,777 | Upgrade
|
| Research & Development | 660.76 | 578.48 | 523.54 | 387.91 | 469.14 | Upgrade
|
| Other Operating Expenses | 55.73 | 44.43 | 46.41 | 45.36 | 45.2 | Upgrade
|
| Operating Expenses | 10,194 | 10,408 | 11,119 | 9,631 | 10,237 | Upgrade
|
| Operating Income | 1,378 | -3,354 | -4,777 | 1,122 | 4,096 | Upgrade
|
| Interest Expense | -651.99 | -2,449 | -2,104 | -818.65 | -801.02 | Upgrade
|
| Interest & Investment Income | 86.74 | 347.08 | 256.72 | 96.61 | 36.2 | Upgrade
|
| Currency Exchange Gain (Loss) | -416.21 | -275.74 | 187.26 | -169.27 | 21.35 | Upgrade
|
| Other Non Operating Income (Expenses) | 90.88 | 380.31 | 2,857 | 6,158 | -8,113 | Upgrade
|
| EBT Excluding Unusual Items | 487.55 | -5,351 | -3,581 | 6,389 | -4,761 | Upgrade
|
| Gain (Loss) on Sale of Investments | 271.47 | 1.67 | 3.37 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 419.04 | 25.32 | - | 141.07 | 14.95 | Upgrade
|
| Asset Writedown | -293.42 | -1,273 | -253.99 | -401.93 | -220.4 | Upgrade
|
| Other Unusual Items | - | -1,463 | - | - | - | Upgrade
|
| Pretax Income | 884.64 | -8,060 | -3,832 | 6,128 | -4,966 | Upgrade
|
| Income Tax Expense | 239.02 | -1,760 | -387.14 | 882.84 | -516.73 | Upgrade
|
| Net Income | 645.61 | -6,300 | -3,445 | 5,245 | -4,449 | Upgrade
|
| Net Income to Common | 645.61 | -6,300 | -3,445 | 5,245 | -4,449 | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 8 | Upgrade
|
| Shares Change (YoY) | 0.74% | -0.05% | -3.40% | 36.03% | 167.50% | Upgrade
|
| EPS (Basic) | 59.00 | -580.00 | -316.96 | 492.55 | -538.00 | Upgrade
|
| EPS (Diluted) | 59.00 | -580.00 | -316.96 | 344.00 | -538.00 | Upgrade
|
| Free Cash Flow | -3,763 | 10,766 | -8,679 | -5,205 | 3,487 | Upgrade
|
| Free Cash Flow Per Share | -343.93 | 991.10 | -798.56 | -462.61 | 421.64 | Upgrade
|
| Gross Margin | 32.46% | 20.73% | 18.52% | 32.13% | 41.47% | Upgrade
|
| Operating Margin | 3.86% | -9.86% | -13.95% | 3.35% | 11.85% | Upgrade
|
| Profit Margin | 1.81% | -18.52% | -10.06% | 15.67% | -12.87% | Upgrade
|
| Free Cash Flow Margin | -10.55% | 31.64% | -25.35% | -15.55% | 10.09% | Upgrade
|
| EBITDA | 3,157 | -746.91 | -2,538 | 3,411 | 6,272 | Upgrade
|
| EBITDA Margin | 8.86% | -2.20% | -7.41% | 10.19% | 18.15% | Upgrade
|
| D&A For EBITDA | 1,779 | 2,607 | 2,239 | 2,289 | 2,177 | Upgrade
|
| EBIT | 1,378 | -3,354 | -4,777 | 1,122 | 4,096 | Upgrade
|
| EBIT Margin | 3.86% | -9.86% | -13.95% | 3.35% | 11.85% | Upgrade
|
| Effective Tax Rate | 27.02% | - | - | 14.41% | - | Upgrade
|
| Advertising Expenses | 59.38 | 268.31 | 271.48 | 197.66 | 83.57 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.